- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
- Locations
-
- City of Hope Duarte, California, United States
- UCLA Hematology/Oncology-Santa Monica Santa Monica, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- The University of Kansas Clinical Research Center Fairway, Kansas, United States
Clinical trial condition
Refractory Metastatic Colorectal Cancer
Explore clinical trials studying Refractory Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Refractory Metastatic Colorectal Cancer trial results
NCT07361003
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Harbin Medical University University Cancer Hospital Harbin, Heilongjiang, China
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
- Cancer Hospital of Shandong First Medical University Jinan, Shandong, China
NCT05991102
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Charité Universitätsmedizin Berlin Berlin, Germany
NCT07261709
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- the first affiliated hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080 Guangzhou, Guangdong, China
Not Yet Recruiting
Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer
NCT06343116
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT04737187
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- City of Hope - South Pasedena South Pasadena, California, United States
- City of Hope - Upland Upland, California, United States
NCT02860546
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
- Locations
-
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Active, Not Recruiting
Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers
NCT05205330
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +16 more
- Locations
-
- Istituto Nazionale dei Tumori Milan, Milano, Italy
- Istituto Oncologico Veneto IRCCS Padova, Italy
- Azienda Ospedaliero Universitaria Pisana Pisa, Italy